secukinumab 300 MG per 2 ML Auto-Injector

RxCUI: 2637347
RxNorm name: secukinumab 300 MG per 2 ML Auto-Injector
Display name: secukinumab 300 MG per 2 ML Auto-Injector
Full name: secukinumab 300 MG per 2 ML Auto-Injector
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:04

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125504	Cosentyx	secukinumab	351(a)	Rx	2026-06-01
761349	Cosentyx	secukinumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
COSENTYX	SECUKINUMAB	Novartis Pharmaceuticals Corporation	77c4b13e-7df3-42d4-81db-3d0cddb7f67a	2026-04-17	Warnings, Adverse reactions	Exact identifier rxcui: 2637347

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
77c4b13e-7df3-42d4-81db-3d0cddb7f67a	secukinumab 300 MG per 2 ML Auto-Injector	SY	29	These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX ® (secukinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2015	20260417
77c4b13e-7df3-42d4-81db-3d0cddb7f67a	2 ML secukinumab 150 MG/ML Auto-Injector	SCD	29	These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX ® (secukinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2015	20260417
77c4b13e-7df3-42d4-81db-3d0cddb7f67a	secukinumab 300 MG in 2 ML Auto-Injector	PSN	29	These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX ® (secukinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2015	20260417